Ganciclovir

3 trials 1 recruiting JAnti-infectives

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

1 Recruiting

2 Completed trials

3 Sponsors

2 Countries

Phase III

Phase II

Phase III: 2 Phase II: 1

Indications tested

Renal transplant 1

Sponsors using this IMP

Fondazione Gimema Franco Mandelli Onlus 1 Fundacion Para La Investigacion Biomedica De Cordoba 1 Fundacion Para La Investigacion Biomedica Del Hospital Gregorio Maranon 1

All trials

3 total

Clinical Trial of Immune-Guided Prevention of CMV Infection in Low-Risk Kidney Transplantation: INMUNOVIR Study. Recruiting

2025-520742-29-00 Phase III 1 country Fundacion Para La Investigacion Biomedica De Cordoba
Study to treat adult patients with Very High-Risk T-cell Acute Lymphoblastic Leukemia (ALL) with Daratumumab in addition to the National ALL… Ended

2024-511627-34-00 Phase II 1 country Fondazione Gimema Franco Mandelli Onlus
CMV preemptive therapy in high-risk immunocompetent major heart surgery patients. A multicenter, double blind, randomized, clinical trial (G… Ended

2022-501429-19-00 Phase III 1 country Fundacion Para La Investigacion Biomedica Del Hospital Gregorio Maranon

Showing 1–3 of 3 trials

← All drugs A–Z